Arylia contains the active substance Denosumab with a protein structure. Denosumab is a human monoclonal antibody (lgG2) that targets and binds with high affinity and specificity to RANKL.
Aryxent
Aryxent
Dupilumab
Aryxent contains the active substance dupilumab. Dupilumab is a monoclonal antibody (a type of specialized protein) that blocks the action of proteins called interleukins (IL-4 and IL-13). Both play a major role in causing the signs and symptoms of disease like atopic dermatitis, asthma, eosinophilic esophagitis (EoE), chronic spontaneous urticaria (CSU), prurigo nodularis (PN) and chronic obstructive pulmonary disease (COPD).
Uses of Aryxent
Indications for Arixent 300 mg/2 mL:
Arixent is a clear to slightly opalescent, colorless to pale yellow solution supplied in a pre-filled syringe.
